MEI Pharma, Inc.
MEIP
$2.05
$0.010.49%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -38.22M | -46.60M | 17.78M | 26.16M | 19.84M |
| Total Depreciation and Amortization | 579.00K | 664.00K | 383.00K | 356.00K | 367.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 13.17M | 15.00M | 15.64M | 3.68M | 4.41M |
| Change in Net Operating Assets | -11.57M | -12.49M | -84.28M | -73.97M | -77.60M |
| Cash from Operations | -36.04M | -43.43M | -50.47M | -43.78M | -52.98M |
| Capital Expenditure | 0.00 | -7.00K | -7.00K | -42.00K | -42.00K |
| Sale of Property, Plant, and Equipment | 10.00K | 10.00K | -- | -6.00K | -13.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 54.81M | 58.88M | 49.15M | 49.04M | 58.95M |
| Cash from Investing | 54.82M | 58.88M | 49.14M | 48.99M | 58.90M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | 0.00 | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -208.00K | -11.87M | -11.87M | -11.66M | -11.66M |
| Cash from Financing | -208.00K | -11.87M | -11.87M | -11.66M | -11.66M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 18.57M | 3.58M | -13.20M | -6.44M | -5.74M |